| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
CCS Cell Culture Service is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our mission at EngageMED is to provide innovative, value-based practice management and revenue cycle services to providers we engage throughout the state of Arkansas.
TriWest Healthcare Alliance is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Rose Medical Group is a not-for-profit, membership-based, multi-specialty Physician Hospital Organization and IPA affiliated with the HealthONE Rose Medical Center in Denver, Colorado.